• Nenhum resultado encontrado

Braz. J. Cardiovasc. Surg. vol.27 número2 en v27n2a26

N/A
N/A
Protected

Academic year: 2018

Share "Braz. J. Cardiovasc. Surg. vol.27 número2 en v27n2a26"

Copied!
1
0
0

Texto

(1)

338

Rev Bras Cir Cardiovasc 2012;27(2):338

RBCCV 44205-1391 DOI: 10.5935/1678-9741.20120054

Cardiothoracic surgeon Paulo M. Pêgo-Fernandes receives Incentive Award in Science and Technology for the SUS - 2011

On April 16 in Brasilia-DF, Dr. Paulo M. Pêgo-Fernandes, associate professor, School of Medicine, University of Sao Paulo and coordinator of the Group of Lung Transplantation, Heart Institute of HC-FMUSP received the Incentive Award in Science and Technology for the SUS -2011 (Fig. 1).

This award, in its 10th edition, an initiative of the Department of Science and Technology Secretariat for Science, Technology and Strategic Inputs of the Ministry of Health (Decit / SCTIE / MS), aims to provide recognition to the researcher in health care for its role in social and economic development in the country.

The award is divided into five categories: Doctoral Thesis, Dissertation, Scientific Paper Published; Monograph Specialization or Residence, and Access to Health System, a new category instituted in commemoration of 10 years of the Prize.

Professor Paulo received an honorable mention in the category Scientific Paper Published for his work “Evaluation and pulmonary reconditioning ex vivo”, published in the Brazilian Journal of Cardiovascular Surgery 2010;25(4):441-6 [1], which has as authors: Paulo Manuel Pêgo-Fernandes, Alessandro Wasum Mariani, Israel Lopes de Medeiros, Artur Eugênio de Azevedo Pereira, Flávio Guimarães Fernandes, Fernando do Valle Unterpertinger, Mauro Canzian and Fabio Biscegli Jatene.

That paper describes the method of ex vivo lung perfusion, developed initially for reconditioning of lungs rejected for transplantation. With this technique, it is expected that the number of lung transplants increase by about 50%, reducing the time on waiting list, which currently is 18 to 24 months to less than 12 months, thus reducing mortality during waiting for a transplant.

Letter to the Editor

Fig.1 - From left to right: President of the Oswaldo Cruz Foundation (FIOCRUZ), Paulo Gadelha; Vice President of ABRASCO -Brazilian Association of Post-Graduate in Collective Health, Luiz Eugênio Portela Fernandes de Souza; Dr. Paulo Pêgo-Fernandes and Health Minister Alexandre Padilha

The ceremony of awards, held during the meeting with the Scientific Community 2012: Science, Technology and Innovation Management in National Development Project, was attended by the Minister of Health, Alexandre Padilha, the Minister of Science and Technology, Marco Antonio Raupp, the Secretary of Science, Technology and Strategic Inputs, Carlos Gabrois Gadelha, and the Director of the Department of Science and Technology, Jailson de Barros Correia.

REFERENCE

Referências

Documentos relacionados

We also used the national budget figures to obtain data on funding according to type of expenditure on S&T: graduate studies and fellowships, basic and applied research,

i) A condutividade da matriz vítrea diminui com o aumento do tempo de tratamento térmico (Fig.. 241 pequena quantidade de cristais existentes na amostra já provoca um efeito

The probability of attending school four our group of interest in this region increased by 6.5 percentage points after the expansion of the Bolsa Família program in 2007 and

The main guidelines for the work by DECIT are provided by the National Agenda for Research Priorities in Health and the Na- tional Policy for Science, Technology, and Innovation

In late 2011, marking an important stage in the development of scientific journals in Brazil, the Brazilian Asso- ciation of Scientific Publishers (ABEC) held its XIII National

CAPITULO 3 TABELA 1 Table 1 - Clinical signs, viral shedding and virus neutralizing VN antibodies in guinea pigs experimentally infected with bovine herpesvirus type 2 in

Os professores entrevistados, manifestaram a ideia generalizada de que a maioria dos alunos dos cursos CEF não reunia condições para o prosseguimento de estudos, por

Caso utilizado em neonato (recém-nascido), deverá ser utilizado para reconstituição do produto apenas água para injeção e o frasco do diluente não deve ser